News Industry News Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD August 07, 2019
News Industry News Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial February 21, 2016
News Industry News Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System August 19, 2015
News Industry News New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months April 28, 2015